Tag: J.P

Sling Therapeutics to Announce Topline Results from Phase 2b/3 LIDS Clinical Trial of Oral Small Molecule Linsitinib in Patients with Thyroid Eye Disease at the 43rd Annual J.P. Morgan Healthcare Conference
Eye Healthcare

Sling Therapeutics to Announce Topline Results from Phase 2b/3 LIDS Clinical Trial of Oral Small Molecule Linsitinib in Patients with Thyroid Eye Disease at the 43rd Annual J.P. Morgan Healthcare Conference

January 15, 2025
admin

ANN ARBOR, Mich., Jan. 13, 2025 /PRNewswire/ — Sling Therapeutics, Inc., a late-stage biopharmaceutical company focused…

Continue Reading
Aurora Spine Announces Attendance at J.P. Morgan Healthcare
Spine Healthcare

Aurora Spine Announces Attendance at J.P. Morgan Healthcare

March 29, 2024
admin

CARLSBAD, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”)…

Continue Reading